BILLS-116hr4764eh.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (15)
2005
2020
each of fiscal years
less than every two years
20
June 30, 2024
4764 EH
fiscal year 2015
8
each of fiscal years 2016
2015
42 U.S.C. 274k(d)(2
each calendar year
later than 2 years
2025
September 30
each of fiscal years 2021
EVENT (2)
SESSION
H. R. 4764
the ‘‘Timely ReAuthoriza-
GPE (2)
the United States of America
the United States
LOC (2)
the Stem Cell
the Stem Cell Therapeutic and Research Act
NORP (1)
APPROPRIATIONS.—To
ORG (30)
the Public Health Service Act
SEC
Senate
Advisory
the House of Representatives
U.S.C.
Committee
the Committee on Health, Education
Energy and Commerce
CONGRESS
Labor
Transplantation Program
Program
the Comptroller General
the Stem Cell Therapeutic and Research Reauthor-
the National Institutes of Health
Programs Lends Access
Resources and Services Administration
ADVISORY COUNCIL
National
House
Drug Administration
Food and Drugs
GAO
Health
NIH
THE FIELD OF REGENERATIVE
Institutes of Health
House of Representa-
Topic Classifications
congressional legislation
98.4%
public health
75.3%
government oversight
70.0%
Extracted Keywords
stem cell
cell
stem
therapies
cells
therapeutic
advisory council
blood
tissue
institutes
section public
medicine
research act
types
service act
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 2.2a Sep 11 2014
- ModDate
- D:20221231071952Z
- Producer
- Acrobat Distiller 20.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20200930112444-04'00'
Sentiment
Polarity
Neutral
0.057
Subjectivity
38%
Objective